Quantcast
Last updated on April 18, 2014 at 9:56 EDT

PRA Recruitment Expert to Speak at Partnerships Session on Experimental Operations

March 5, 2012

RALEIGH, N.C., March 5, 2012 /PRNewswire/ — PRA, a leading Clinical Research Organization, announces that one of our Patient Access and Retention Services (PARS) experts will speak at the 21st Annual Partnerships(TM) in Clinical Trials being held in Orlando from 4-7 March. PRA will also host an exhibit at booth 219, where additional company representatives will be available to discuss our approach to clinical trials.

On 7 March at 11:15AM EST, Gretchen Goller, PRA’s Senior Director of PARS, will participate in the session, “eClinical Technology & Data Management.” The session will review the novel approaches tested during a recent “experimental operations” pilot program that PRA supported for one of the world’s leading biopharmaceutical companies. Ms. Goller will discuss the challenges and benefits of experimental operations, site and investigator communication and the risks of using new technologies.

During her 15+ years of clinical research experience, Ms. Goller has served as a patient recruitment and retention strategist, clinical team manager and site director. Her therapeutic background includes ophthalmology, women’s health, HIV/AIDS, cardiology and endocrinology. In her role with PRA’s PARS group, Ms. Goller works with a team of strategists to implement recruitment and retention programs on all pertinent PRA studies.

PARS is a division within PRA Therapeutic Expertise, a specialized unit comprised of highly respected therapeutic experts. The PARS team works closely with strategic partners to provide consultation, programs, materials and services for the most effective and cost-efficient approaches to achieving enrollment goals and ensuring patient adherence to study requirements.

About PRA

PRA is transforming clinical trials through our people, innovation and transparency. PRA provides personalized service customized to the unique requirements of each study. We support our global reach and innovative approach through flexible and reliable service, delivered by skilled employees dedicated to ensuring that sponsors achieve their long-term goals.

We serve our clients across all phases of pharmaceutical and biotech drug development by combining therapeutic and operational expertise with local knowledge. Offering services in 80+ countries and serving sponsors for 30+ years, we have amassed a level of expertise that has enabled us to work on a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs. But at PRA, we are looking to the future, not the past. Our increasingly forward-thinking approach to transforming the clinical trial landscape will continue to make a difference to healthcare patients around the world.

To learn more about PRA, please visit praintl.com, email endpoints@praintl.com or call our Global Headquarters.

SOURCE PRA


Source: PR Newswire